Kunming, China

Weilie Xiao

This inventor holds 2 USPTO granted patents. Top assignees: Chinese Academy of Sciences, Yunnan University, East China University of Science and Technology. Active years: 2016-2022.


% Patents Active = 50.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2016-2022

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Weilie Xiao in Pharmaceutical Chemistry

Introduction

Weilie Xiao is a prominent inventor based in Kunming, China, known for his significant contributions to pharmaceutical chemistry. With a focus on developing innovative compounds, he has made strides in the field of medicinal applications.

Latest Patents

Weilie Xiao holds two notable patents. The first patent is titled "Saponin compound targeting PD-1 and application thereof." This invention involves the use of a saponin compound in the manufacture of a medicament that targets PD-1, which is crucial for treating various diseases, including tumors and infections caused by bacteria, viruses, or fungi. The second patent is for "Nitrogen-containing biphenyl compounds, pharmaceutical compositions of same, preparation methods and anti-HIV-1 uses thereof." This patent details nitrogen-containing biphenyl compounds and their pharmaceutical applications, particularly in the fight against HIV-1.

Career Highlights

Weilie Xiao has worked with esteemed institutions such as the Chinese Academy of Sciences and Yunnan University. His experience in these organizations has allowed him to collaborate with leading researchers and contribute to groundbreaking advancements in pharmaceutical science.

Collaborations

Throughout his career, Weilie Xiao has collaborated with notable colleagues, including Honglin Li and Lili Zhu. These partnerships have fostered a productive environment for innovation and research.

Conclusion

Weilie Xiao's work exemplifies the impact of innovative thinking in pharmaceutical chemistry. His patents reflect a commitment to addressing critical health challenges through scientific advancements.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…